The industry met a new milestone in the regulatory field this part year – 2011 saw a seven year high of FDA approvals with 30 drug approvals.  Among those receiving multiple approvals were Johnson & Johnson and GlaxoSmithKline.  Will that number stay high in 2012 and in years to come?    To find out more, click here.